Table 1.
EIN Classification
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cases
|
Controls
|
|||||||||
Inadequate | Benign | EIN | Cancer | Total | Inadequate | Benign | EIN | Cancer | Total | |
EH | ||||||||||
Classification | ||||||||||
Community WHO | ||||||||||
DPEM | 1 (4%) | 16 (64%) | 4 (16%) | 3 (12%) | 25 | - | - | - | - | - |
SH | 5 (10%) | 26 (50%) | 16 (31%) | 5 (10%) | 52 | 3 (5%) | 52 (85%) | 5 (8%) | 1 2%) | 61 |
CH | 2 (5%) | 22 (50%) | 16 (36%) | 2 (5%) | 44 | 1 (1%) | 63 (63%) | 29 (29%) | 5 (5%) | 100 |
AH | 1 (6%) | 7 (41%) | 6 (35%) | 3 (18%) | 17 | 0 (0%) | 44 (55%) | 31 (39%) | 4 5%) | 80 |
Total | 9 (7%) | 71 (51%) | 42 (30%) | 13 (9%) | 138 | 4 (2%) | 159 (66%) | 65 (27%) | 10 (4%) | 241 |
| ||||||||||
Cases
|
Controls
|
|||||||||
Inadequate | Benign | EIN | Cancer | Total | Inadequate | Benign | EIN | Cancer | Total | |
| ||||||||||
Panel WHO | ||||||||||
DPEM | 3 (9%) | 29 (88%) | 1 (3%) | 0 (0%) | 33 | 4 (4%) | 84 (87%) | 6 (6%) | 1 (1%) | 95 |
SH | 2 (5%) | 32 (78%) | 5 (12%) | 2 (5%) | 41 | 0 (0%) | 60 (90%) | 7 (10%) | 0 (0%) | 67 |
CH | 2 (10%) | 1 (5%) | 15 (71%) | 2 (10%) | 20 | 0 (0%) | 12 (28%) | 23 (53%) | 7 (16%) | 42 |
AH | 2 (5%) | 9 (21%) | 21 (49%) | 9 (21%) | 41 | 0 (0%) | 3 (9%) | 29 (85%) | 2 (6%) | 34 |
Total | 9 (7%) | 71 (51%) | 42 (30%) | 13 (9%) | 135 | 4 (2%) | 159 (66%) | 65 (27%) | 10 (4%) | 238 |
DPEM, disordered proliferative endometrium. SH, simple hyperplasia. CH, complex hyperplasia. AH, atypical hyperplasia. EIN, endometrial intraepithelial neoplasia.
Community WHO refers to the original EH diagnoses at KPNW (1970–2003). EIN and Panel WHO were independently assigned by separate panels of gynecologic pathologists.
Cases with community WHO diagnoses of DPEM were eligible for inclusion, but all controls had a community WHO diagnosis of SH, CH, or AH.
Slides from 3 cases and 3 controls were not available for review.
Row percentages might not sum to 100 because of rounding.